Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients

Friebus-Kardash J, Gackler A, Kribben A, et al. Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients. Transpl Infect Dis. 2019;21:e13146.

Publication Type:

Journal Article

Authors:

Friebus-Kardash, J; Gackler, A; Kribben, A; et, al

Source:

Transpl Infect Dis, Volume 21, p.e13146 (2019)

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

Export Citation:

RIS Format

Top